Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancer
Article in Expert Opinion on Drug Metabolism & Toxicology (March 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Efficacy and safety of anlotinib plus XELOX regimen as first-line therapy for mCRC: a single-arm, multicenter, phase II study (ALTER-C-001)
Article in Frontiers in Oncology (September 2023)
Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene
Article in Cancers (July 2022)